NCT02202473View on ClinicalTrials.gov

Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

192

Participants

Timeline

Start Date

Not specified

Primary Completion Date

February 28, 2014

Conditions

Chronic Hepatitis B

Interventions

DRUG

Lamivudine

DRUG

Lamivudine+Oxymatrine Capsules

Trial Locations (1)

210000

the second hospital of Nanjing, Nanjing

All Listed Sponsors

collaborator

Cttq

INDUSTRY

lead

Southeast University, China

OTHER

NCT02202473 - Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects | Biotech Hunter | Biotech Hunter